↓ Skip to main content

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19

Overview of attention for article published in Frontiers in Pharmacology, August 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
twitter
2 X users
patent
2 patents
video
1 YouTube creator

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
198 Mendeley
Title
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
Published in
Frontiers in Pharmacology, August 2020
DOI 10.3389/fphar.2020.01258
Pubmed ID
Authors

Rudra P. Saha, Ashish Ranjan Sharma, Manoj K. Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, Manojit Bhattacharya, Sang-Soo Lee, Chiranjib Chakraborty

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 198 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 198 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 26 13%
Student > Master 25 13%
Student > Bachelor 20 10%
Student > Ph. D. Student 15 8%
Other 15 8%
Other 26 13%
Unknown 71 36%
Readers by discipline Count As %
Medicine and Dentistry 36 18%
Biochemistry, Genetics and Molecular Biology 26 13%
Pharmacology, Toxicology and Pharmaceutical Science 20 10%
Nursing and Health Professions 8 4%
Chemistry 6 3%
Other 31 16%
Unknown 71 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2022.
All research outputs
#2,287,716
of 23,393,453 outputs
Outputs from Frontiers in Pharmacology
#881
of 16,895 outputs
Outputs of similar age
#62,152
of 401,048 outputs
Outputs of similar age from Frontiers in Pharmacology
#39
of 449 outputs
Altmetric has tracked 23,393,453 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,895 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 401,048 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 449 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.